IntelGenx Technologies Corp. Files POS AM with the SEC

IntelGenx Technologies Corp. submitted a POS AM (Post-Effective Amendment) filing to the Securities and Exchange Commission, indicating a significant development within the company. A Post-Effective Amendment is a form used to update or amend a previously filed registration statement. In this case, IntelGenx Technologies Corp. likely made changes to the details of a previously registered offering, such as the offering amount or the number of shares being offered.

IntelGenx Technologies Corp. is a pharmaceutical company that focuses on the development and manufacturing of novel oral thin film drug delivery products. The company’s innovative technologies allow for the effective and convenient delivery of medications. With a commitment to improving patient outcomes through proprietary drug delivery technologies, IntelGenx continues to advance its pipeline of products.

For more information about IntelGenx Technologies Corp. and its cutting-edge drug delivery solutions, please visit their website at https://www.intelgenx.com/.

Read More:
IntelGenx Technologies Corp. Submits POS AM SEC Filing (Form Type: POS AM)